Freedom Investment Management’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Freedom Investment Management’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,785	Closed	-$11K	–	820
2024 Q4	$11K	Buy	14,785 +2,247	+18%	+$2.24K	﹤0.01%	750
2024 Q3	$15.3K	Buy	+12,538	New	+$20K	﹤0.01%	757

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Freedom Investment Management's OMGA Position: Q1 2025 in Review

Freedom Investment Management sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 14,785 shares — an estimated $11K sold.

Freedom Investment Management first reported a position in OMGA in Q3 2024 and held it in 2 quarters. The position peaked at $15.3K in Q3 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

Freedom Investment Management reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Freedom Investment Management sold 14,785 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $11K.
Freedom Investment Management first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2024 and held it in 2 quarters.
Freedom Investment Management's Omega Therapeutics, Inc. Common Stock position peaked at $15.3K in Q3 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Freedom Investment Management's 13F filing for Q1 2025, filed 14 May 2025.